Fig. 2From: Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled studyEffects of non-high-flow nasal therapy (HFNT) pulmonary rehabilitation (PR) vs. HFNT PR on the modified Medical Research Council (mMRC) scale. a. Individual changes in mMRC in both groups at the baseline, and after 4 and 12 weeks of the intervention. b. Comparisons of delta-mMRC (changes from the baseline after 4 and 12 weeks; mean ± SD) between the two groupsBack to article page